|
|
| Formerly known as: |
| Sanofi-Synthelabo S.A. |
 |
| Primary Symbol & Exchange: |
| SAN - Common Stock - Euronext Paris |
| Other Symbols & Exchanges: |
| SNY - ADR - New York Stock Exchange |
| SNW - Dual listed - Frankfurt |
|
|
| Industry: |
| Pharmaceutical |
|
|
|
|
|
|
|
| Mergers & Acquisitions: |
| Sanofi-Aventis S.A. Mergers and Acquisitions
|
|
Thomson Financial Business Description:
| The Group's principal activities are the research, production and distribution of pharmaceuticals products. It operates under two segments: Pharmaceuticals and Vaccines. Under the Pharmaceuticals segment, it manufactures medicines for the following therapeutic areas: Cardiovascular, thrombosis, central nervous system, oncology, metabolic disorders and internal medicine. Under the Vaccines segment: the Group manufactures vaccines utilized for treating tetanus, whooping cough, diphtheria, HIV/AIDS and hepatitis B. Their brands include: Lovenox, Plavix, Lantus, Taxotere, Eloxatine, Stilnox, Copaxone, Aprovel, Tritace, Allegra, Amaryl, Xatral, Actonel, Depakine and Nasacort. The Group operates throughout the world. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Sanofi-Aventis S.A.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
